Thumbnail Image
Item

A plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are not expected to receive a stem cell transplant

Usmani, Saad Z.
; 
Facon, Thierry
; 
Hungria, Vania
; 
Bahlis, Nizar J.
; 
Venner, Christopher P.
; 
Braunstein, Marc
; 
Pour, Ludek
; 
Martí, Josep M.
; ; 
Cohen, Yael C.
... show 10 more
Authors
Usmani, Saad Z.
 Facon, Thierry
 Hungria, Vania
 Bahlis, Nizar J.
 Venner, Christopher P.
 Braunstein, Marc
 Pour, Ludek
 Martí, Josep M.
 Basu, Supratik
 Cohen, Yael C.
 Matsumoto, Morio
 Suzuki, Kenshi
 Hulin, Cyrille
 Grosicki, Sebastian
 Legiec, Wojciech
 Beksac, Meral
 Maiolino, Angelo
 Takamatsu, Hiroyuki
 Perrot, Aurore
 Turgut, Mehmet
 Ahmadi, Tahamtan
 Liu, Weiping
 Wang, Jianping
 Chastain, Katherine
 Vermeulen, Jessica
 Krevvata, Maria
 Lopez-Masi, Lorena
 Carey, Jodi
 Rowe, Melissa
 Carson, Robin
 Zweegman, Sonja
Editors
Other contributors
Affiliation
Faculty of Science and Engineering, University of Wolverhampton
Epub Date
Issue Date
2025-12-31
Submitted date
Subjects
CEPHEUS
 daratumumab
 D-VRd
 multiple myeloma
 newly diagnosed
 transplant ineligible
 transplant deferred
Show all metadata
Files
Under embargo
Adobe PDF, 2.17 MB
Alternative
Abstract
Citation
Usmani, S.Z., Facon, T., Hungria, V. et al. (in press) A plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are not expected to receive a stem cell transplant. Future Oncology.
Publisher
Taylor & Francis
Journal
Future Oncology
Research Unit
URI
https://wlv.openrepository.com/handle/2436/626067
DOI
PubMed ID
PubMed Central ID
Embedded videos
Additional Links
https://www.tandfonline.com/journals/ifon20
Type
Journal article
Language
en
Description
This is an author's accepted manuscript due to be published by Taylor & Francis in Future Oncology [date tbc], available online at [link tbc]. The accepted manuscript may differ from the final published version.
Series/Report no.
ISSN
1479-6694
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
This manuscript was funded by Johnson & Johnson.
Rights
Research Projects
Organizational Units
Journal Issue
Embedded videos
Collections
Faculty of Science and Engineering